Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review).

Jiahao Li, Lei Xian, Zifeng Zhu, Yang Wang, Wenlei Zhang, Ruipeng Zheng, Wang Xue, Jiarui Li

Journal: International journal of molecular medicine 2023;52(4):88

PMID: 37594127

Abstract

Ferroptosis is a novel form of regulated cellular necrosis that plays a critical role in promoting cancer progression and developing drug resistance. The main characteristic of ferroptosis is iron‑dependent lipid peroxidation caused by excess intracellular levels of reactive oxygen species. CUGBP ELAV‑like family number 2 (CELF2) is an RNA‑binding protein that is downregulated in various types of cancer and is associated with poor patient prognoses. CELF2 can directly bind mRNA to a variety of ferroptosis control factors; however, direct evidence of the regulatory role of CELF2 in ferroptosis is currently limited. The aim of the present review was to summarise the findings of previous studies on CELF2 and its role in regulating cellular redox homeostasis. The present review may provide insight into the possible mechanisms through which CELF2 affects ferroptosis and to provide recommendations for future studies.

Address: Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.